C P J / R P C • J a n u a r y / F e b r u a r y 2 0 1 4 • V O L 1 4 7 , N O 1 3 3 ORIGINAL RESEARCH PeeR-ReViewed ABSTRACT Background: Influenza is a major cause of morbidity and mortality in Canada, with up to 7000 influenza-related deaths occurring every year. The elderly and individuals with chronic diseases are at increased risk for influenza-related morbidity and mortality.
Our research was designed to evaluate and provide innovative solutions for the many barriers that exist with respect to decreased vaccine uptake in rural communities. Our project is intended to promote immunization programs to the public and improve access to immunization services by looking for innovative ways to extend service provision.
Notre recherche est destinée à évaluer et à proposer des solutions innovantes pour surmonter les nombreux obstacles reliés à la diminution des taux de vaccination dans les communautés rurales. Elle sert à promouvoir les programmes de vaccination auprès du public et à améliorer l' accès aux services de vaccination en cherchant des moyens innovants d' offrir ces services.

Background
Influenza virus (A and B) is a major cause of morbidity and mortality in Canada. 1, 2 Early clinical symptoms of influenza-like illness (ILI) include onset of respiratory illness, fever, cough and 1 or more of the following: sore throat, arthralgia, myalgia or prostration with accompanying gastrointestinal symptoms in children less than 5 years of age. 1 Those at highest risk are individuals 65 years and older, accounting for 90% of deaths, as well as individuals with chronic diseases (e.g., diabetes mellitus, cancer, FAwzIAh MARRA ORigiNaL ReseaRCh immunodeficiency, immunosuppression, renal disease, anemia, hemoglobinopathies), pregnant women, and children aged 6 to 23 months. 3 Annual influenza vaccination (containing inactivated A/H1N1, A/H3N2 and 1 influenza B virus) of individuals at high risk of influenza complications remains the primary strategy for reducing influenza-related morbidity and mortality in community and long-term care settings. 3, 4 In British Columbia (BC), influenza vaccine is provided free of charge to at-risk groups, as recommended by the National Advisory Committee on Immunization (NACI); however, despite access to free vaccines, adult immunization rates have remained suboptimal (i.e., below the 90% targeted goal set by NACI) and fluctuate considerably both over time and across different regions of the province. 4 For example, in 2007, the overall BC influenza vaccine rate was 59% (95% CI 56%-63%) for those 65 years of age and over and 40% (95% CI 39%-42%) for those younger than 65 years with at least 1 chronic medical condition. 5, 6 The main motivating factor for influenza vaccine uptake is a recommendation from a health care professional, while barriers include lack of knowledge, inconvenience, inaccessibility, allergy to eggs and concerns over adverse events. 7, 8 Immunization promotion, accessibility and health care provider intervention are believed to be important organizational factors facilitating the uptake of influenza vaccination. 7, 8 There are approximately 3000 pharmacists practising in BC. Pharmacists are considered among the most easily accessible health care professionals available to the public. 9 With an expanding scope of practice moving from product-oriented to patient-centred care, pharmacists are in an ideal position to deliver optimal pharmaceutical care services such as chronic disease management, adapting or writing prescriptions, emergency contraception, and injections, including vaccinations. 9 Through regular contact with high-risk individuals, pharmacists have the ability to act as health care interventionists by reminding patients about the benefits of vaccination and taking a proactive, systemic approach in addressing this potential health care need. 9 In Canada, the impact of using pharmacybased vaccination strategies on immunization rates has not been studied. The goal of this study was to determine whether a patient-centred immunization strategy based in community pharmacies could improve vaccination rates in small rural communities. Ethics approval for this study was obtained from the University of British Columbia's Clinical Research Ethics Board, and consent was obtained from all patients who participated in the intervention arm.
Methods
Community selection and randomization
The 2006 Canadian Census was used to identify 29 communities meeting our inclusion criteria (townships, first nations reserves, amalgamated townships and counties were excluded) of population size between 2000 and 6000 and with no recent geopolitical amalgamation. These communities were located within 2 health authorities in British Columbia-Northern Health and Interior Health Authorities-and each had at least 1 pharmacy in the community. Communities were stratified by size and randomly assigned to the intervention or control arm using a computer-generated randomization sequence. All pharmacies in participating communities were identified using the College of Pharmacists of BC listing of community pharmacies within the province. In addition, participating pharmacists in each community were asked to identify any pharmacies that were missed.
Target population
The target population was those who were at "high risk" of influenza-related adverse
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• The elderly and individuals with chronic diseases are at increased risk for influenza-related morbidity and mortality, and the influenza vaccine is highly recommended for these individuals. • Not all small rural communities have access to a public health office, but they do have access to at least 1 pharmacy. • Pharmacists, who are among the most accessible health care providers, can play a significant role by sending reminder letters to their clients, providing extended service hours, educating clients on risk and benefits of the vaccine and administering vaccinations. • This trial demonstrates that pharmacist-based influenza clinics increased immunization rates for older adults. • Patients supported pharmacists as immunization providers and liked the fact that pharmacies offered extended hours.
Original research outcomes, such as those 65 years and older and those between the ages of 2 and 64 years with at least 1 chronic condition. These 2 groups are eligible to receive free, publicly funded vaccines in the province of British Columbia. These individuals were identified based on prescriptions filled for 1 or more medications for chronic diseases, such as cardiac or pulmonary disorders (e.g., bronchopulmonary dysplasia, cystic fibrosis, asthma, chronic obstructive pulmonary disease), diabetes or other metabolic diseases, cancer, immunodeficiency (including human immunodeficiency virus [HIV] infection), immunosuppression due to underlying disease or therapy (e.g., rheumatoid arthritis requiring immunosuppressive therapies), chronic kidney disease, chronic liver disease, anemia and hemoglobinopathy, and conditions that compromise the management of respiratory secretions and are associated with an increased risk of aspiration (e.g., cognitive dysfunction, spinal cord injury, seizure disorder and neuromuscular disorders). 10 Intervention and control communities All pharmacies in the intervention communities were approached and invited to participate. The strategies provided by pharmacies allocated to the intervention arm included the standardized training of pharmacists on providing injections and the use and safety monitoring of influenza vaccination. All the pharmacists who provided immunizations as part of this study had received training through the accredited "Administration of Injections" course provided by the BC Pharmacy Association. This program is made up of 2 components: an online prestudy called the Immunization Competency Program and an in-person workshop called the Practical Administration of Injections for BC Pharmacists. In addition to participating in this program, pharmacists need to provide valid certificates for cardiopulmonary resuscitation and first aid before being granted the authority to administer injections by the College of Pharmacists of BC. 11 The pharmacists generated personalized invitation letters to the eligible clients (based on age or filled prescription for 1 or more medications for a chronic medical condition), which were directed to their clients (target population), inviting them to be vaccinated at the pharmacy clinics. There was also public promotion of the pharmacy-based clinics through advertisements in the media, such as local papers, radio and cable TV, and in pharmacy-based posters. In addition, posters within the pharmacies advertised the influenza vaccination clinics, which included the hours of service and eligibility criteria. Participating pharmacies were encouraged to hold 1 or 2 clinics per week during the influenza vaccination period (October 15 to December 31) and had a dedicated nurse or pharmacist to educate patients on the benefits of vaccination, to vaccinate patients, monitor for potential adverse events and provide education on influenza prevention (e.g., handwashing, lack of effect of antibiotics for influenza).
The strategies described above were not made available to pharmacies in the control communities during the 2 years of the study.
Measurement of outcomes
The primary outcome was the difference in the mean influenza vaccination rates in the intervention and control communities in 2009 and 2010. Data on influenza immunization rates were obtained at the community level for the entire population of residents 65 years and older and those between 2 to 64 years with at least 1 chronic medical condition. To estimate the number of patients with chronic medical conditions in each community, we used CIHI and CCHS data, which indicate that approximately 30% of individuals aged 2 to 64 years have at least 1 chronic illness. 12 
MISE EN PRATIQUE DES CONNAISSANCES
• Les personnes âgées et celles qui souffrent de maladies chroniques ont des risques accrus de morbidité et de mortalité liés à la grippe, c'est pourquoi le vaccin antigrippal est fortement recommandé chez ces personnes. • Toutes les communautés rurales n'ont pas accès à un bureau de santé publique, mais elles ont au moins une pharmacie accessible. 
ORigiNaL ReseaRCh
Data on the number of vaccinations given to individuals in our 2 study populations were obtained from the 2 health authorities. The data from the health authorities on influenza vaccinations are collected from all immunizers in the community (i.e., physician offices, pharmacies, public health units) in aggregate format by each health unit during each influenza season.
All participants at the pharmacy-based influenza clinics were asked to complete a short questionnaire during both years in which the intervention occurred. Questions regarding demographics, socioeconomic status, medical status, vaccination history and reasons for attending the pharmacy-based clinics were analyzed as secondary outcomes.
Analysis
The main analysis used the intention-totreat approach and was based on a 2-sample independent t test comparing mean immunization rates in each cluster aggregated across the 2 allocation arms. None of the randomized communities were excluded, and the patients were analyzed according to the randomization scheme. The results were reported as estimates of the differences between arms, 95% confidence interval and associated p values. For all tests, we used alpha = 0.05 level of significance. All analyses were performed using SAS version 9.2 (Cary, North Carolina). Figure 1 shows the trial profile. In 2009, of the 29 eligible communities, only 24 elected to participate. The communities that did not participate had only 1 pharmacy in the community and were too short-staffed to arrange Table 1 . Table 2 shows the impact of using pharmacybased vaccination strategies on immunization rates for the year 2009 (we used these as our baseline rates). Because this was the pandemic year, 2 influenza vaccination programs were rolled out across Canada-the seasonal influenza campaign with the trivalent vaccine and the pandemic H1N1 vaccine campaign. 
Results
Study implementation and demographics
Immunization rates
ORigiNaL ReseaRCh
For British Columbia, the trivalent seasonal vaccine campaign was offered in 2 phases; the first phase was for individuals 65 years of age or older, beginning mid-October, while the second phase, beginning mid-November, was for those at high risk of influenza complications. In reality, only those patients 65 years of age or older were immunized with the seasonal vaccine, as the H1N1 vaccine was rolled out to the entire population as soon as it became available in mid-November. 13 The mean rate of immunization in the 14 (Table 3) .
Reasons for attending pharmacy-based clinics
Most participants had received an influenza vaccination the year prior to the influenza season, with the majority of the participants receiving their vaccination at a public health clinic ( Table 4 ). As was expected, there was a high association between the respondents having the influenza vaccination in previous years with those coming in for influenza vaccination the current year. Approximately one-third of the participants heard of the influenza vaccination clinic at the pharmacy from the local newspaper, and just over 20% came to the pharmacy because of a personalized letter from their pharmacist. The most common reason provided by the participants for coming to the influenza clinic was because of the expanded hours associated with pharmacies.
Discussion
We demonstrated that a pharmacist-based intervention improved immunization rates in the elderly (those ≥65 years) within small rural communities. However, our study did not observe a difference in those between the ages of 2 and 64 years with a chronic medical condition.
Implemented strategies that largely contributed to improvements in vaccination rates were newspaper advertisements and personalized mail-out invitation letters from the pharmacist. This outcome is supported by a systematic review by Ompad et al., 14 who showed that advertising and patient mailings, along with telephone calls and patient/staff education, are interventions that enabled practitioners to meet the Healthy People 2010 targets (i.e., 90% vaccination for noninstitutionalized patients ≥65 years). Similarly, a systematic review conducted by the Cochrane Collaboration noted that any form of patient reminder, including letters and advertisements, did improve immunization rates, regardless of patient age or type of setting. 15 Intervention strategies that were found to be the most effective often contained an element of personalization or increased exposure to the general community. Strategies such as personalized invitations, local newspaper advertisements, walk-in capability and word of mouth (by friends or family) showed greater value in increasing awareness of pharmacy-based influenza clinic immunization opportunities in comparison to general flyers from the pharmacy or in the community. Other studies have also shown that increasing the frequency and degree of personalization in advertising is effective in increasing immunization rates. In addition, multiple intervention strategies likely contribute to increasing vaccination rates-in other words, a combination of interventions is better than 1 specific intervention at increasing vaccination rates. [16] [17] [18] Our survey showed that a large proportion of participation in a pharmacy-based influenza clinic was due to convenience (i.e., participants could pick up other items from store, or opening hours were extended). A survey conducted in Nova Scotia by Corsten et al. 19 also revealed that 80% of participants preferred pharmacybased clinic immunization due to convenience. Therefore, involvement of qualified pharmacists, who are highly accessible in rural communities, as vaccinators may be the key in developing a multicomponent immunization approach.
Our study had a number of limitations, with the largest being that its first year coincided with the H1N1 pandemic. 20, 21 As a result, seasonal vaccine was only indicated for those 65 years and older in that year, which meant that we could not draw conclusions from those 2 to 64 years Clients immunized in a community/population with chronic conditions in that community (assumed to be 30%). **Assuming the communities with greater than 100% immunization rates had a maximum of 100% immunization. Original research of age with chronic medical conditions. Given our findings for the year 2010, where we did not see a significant increase in immunization rates within the 2 to 64 years of age cohort but did for the elderly, it would have been important to include this group in the first year of our study as well. In addition, it is not clear how the H1N1 pandemic affected the following year's influenza vaccination rates. Another difference between 2009 and 2010 influenza seasons was that in the first year of our study, most of the pharmacybased clinics were led by nurses and were by appointment only or had limited scheduled times, as the pharmacists were not yet certified to give injections and therefore needed to hire a nurse to run their clinics. By 2010, the majority of the clinics were run by pharmacists and so hours of operation and number of clinics offered were greater. This aspect may have contributed to the effect seen in 2010 but not in 2009 for those over 65 years of age and older. Another limitation of our study was lack of accurate denominator data. This posed 2 problems for us-one was that the numerator sometimes exceeded the denominator, which gave us vaccination rates of over 100%. While these rates were set to 100% in our calculations of the immunization rates, this is clearly a limitation. However, we believe this was likely the result of a significant number of people driving from adjacent areas and receiving their vaccinations in the study communities. Accurate data are lacking regarding the number of patients with chronic medical conditions in each community, so we had to estimate the proportion of patients with a chronic medical condition within the chosen communities based on CIHI and CCHS data, which suggest that approximately 30% of individuals aged 2 to 64 years have a chronic illness. Although 2028 surveys were assigned participant ID numbers, only 1998 were completed. Of the completed questionnaires, some had missing data that could have biased the results. In addition, like all questionnaires, a certain degree of subjectivity is always present.
Original research
Participant honesty, memory and motivation to complete the survey are all variables that could have skewed the results. A further limitation would be the representativeness of the sample given that the data are self-reported. Although participants chosen to complete the surveys were randomly sampled, errors due to no response may exist; people who chose to respond to the survey may have been different from those who did not, thus leading to a biased response rate as a result of confounding variables.
Pharmacists, with their expanding scope of practice, are among the most accessible health care professionals available to the general public and can be at the forefront of public health initiatives. Pharmacists are in an ideal place to act as public health care interventionists through proactive identification and engagement with patients. As a result of legislation that allows a pharmacist to immunize, the convenient locations of pharmacies, extended opening hours and overall accessibility, the lack of availability of public health clinics in small rural locations means that the establishment of pharmacy-based clinics in rural areas can aid in achieving higher rates of vaccination. The results of this study suggest that by promoting immunization programs publicly and improving access to immunization services as a result, communities can increase immunization coverage rates-leading to predictable outcomes such as improvement in patient quality of life through reduced morbidity and mortality and a reduction in health care cost.
Conclusion
In a cluster-randomized trial of pharmacist intervention to improve influenza vaccination rates, we demonstrated an improvement in vaccination in patients 65 years of age and older. Given these findings, we suggest that the use of multiple strategies to increase education of the provider, increase community demand and decrease barriers for vaccinations can result in higher vaccination rates. ■ 
